-
three different forms of
galectin structure: dimeric,
tandem or chimera.
Dimeric galectins, also
called prototypical galectins, are homodimers, consisting...
-
Galectin-3 is a
protein that in
humans is
encoded by the LGALS3 gene.
Galectin-3 is a
member of the
lectin family, of
which 14
mammalian galectins have...
- binding. The
galectins are a
family of beta-galactoside-binding
proteins implicated in
modulating cell-cell and cell-matrix interactions.
Galectin-1 may act...
-
involvement of
different galectins should be take into
consideration when
correlating the
expression level and the malignancy.
Galectin-9,
through its cytoplasmic...
-
Galectin-4 is a
protein that in
humans is
encoded by the LGALS4 gene. The
galectins are a
family of beta-galactoside-binding
proteins implicated in modulating...
-
Galectin-7 is a
protein that in
humans is
encoded by the LGALS7 gene. The
galectins are a
family of beta-galactoside-binding
proteins implicated in modulating...
-
galectin family.
Galectins are beta-galactoside-binding
animal lectins with
conserved carbohydrate recognition domains. The
galectins have been implicated...
-
Galectin-2 is a
protein that in
humans is
encoded by the LGALS2 gene. The
protein encoded by this gene is a
soluble beta-galactoside
binding lectin. The...
-
Belapectin (also
known as GR-MD-02) is a
galectin-3
inhibitor developed by
Galectin Therapeutics that is in
clinical trials for the
treatment of non-alcoholic...
- July 1, 2013. In 2021,
Carson joined Galectin Therapeutics to ****ist with
development of the company's
galectin-3 inhibitor, belapectin, as a treatment...
